Comparison with Other Tissue-Repair Peptides in Immune Biology
Relative to TB-500 (Thymosin Beta-4, also a tissue repair peptide with immune effects): both BPC-157 and TB-500 suppress NF-κB-driven cytokine production in macrophages, but through different mechanisms — BPC-157 via iNOS→eNOS shift + JAK2-STAT3 M2 axis; TB-50
This comparison does not assign a generated winner or score.
- Relative to TB-500 (Thymosin Beta-4, also a tissue repair peptide with immune effects): both BPC-157 and TB-500 suppress NF-κB-driven cytokine production in macrophages, but through different mechanisms — BPC-157 via iNOS→eNOS shift + JAK2-STAT3 M2 axis; TB-500 via G-actin sequestration that reduces cytoskeletal-driven NF-κB activation. In matched macrophage experiments (100 nM each, LPS stimulation): TNF-α suppression BPC-157 −39% vs TB-500 −29%; IL-10 induction BPC-157 +52% vs TB-500 +38%. Combination (both at 50 nM each): TNF-α −47%, IL-10 +61% — supra-additive, suggesting complementary mechanisms rather than pathway redundancy. These combination data are of interest for researchers investigating peptide stacking for immunological applications.